Table 9.9b

Unadjusted Graft Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	904	85.5%	1.2%	904	79.3%	1.4%	336	68.7%	2.6%	147	78.1%	3.5%
Primary Diagnosis	Non-Cholestatic Cirrhosis	442	86.3%	1.6%	442	80.5%	1.9%	108	61.4%	4.8%	12	58.3%	14.2%
	Cholestatic Liver Disease/Cirrhosis	150	83.1%	3.1%	150	79.0%	3.4%	30	79.9%	7.4%	2	100.0%	0.0%
	Acute Hepatic Necrosis	63	81.0%	4.9%	63	71.4%	5.7%	37	65.2%	8.1%	18	77.4%	10.0%
	Biliary Atresia	95	84.9%	3.7%	95	79.5%	4.2%	83	75.6%	4.7%	89	82.3%	4.2%
	Metabolic Diseases	31	90.0%	5.5%	31	70.0%	8.4%	16	74.5%	11.0%	15	73.3%	11.4%
	Malignant Neoplasms	57	89.5%	4.1%	57	80.6%	5.3%	26	57.7%	9.7%	3	66.7%	27.2%
	Other	66	84.6%	4.5%	66	83.0%	4.7%	36	73.1%	7.7%	8	+	+

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.